Thank you for listening to this week's episode! Be sure to subscribe for weekly updates in the world of pharma. LINKS: Story #1 https://www.biopharmadive.com/news/fda-investigation-aduhelm-alzheimers-drug-approval-biogen/603122/ Link to Janet Woodcock’s tweet: https://twitter.com/DrWoodcockFDA/status/1413540801934774283 Story #2 https://www.biopharmadive.com/news/lilly-acquire-protomer-glucose-sensitive-insulin/603325/ Story #3 https://www.statnews.com/2021/07/13/aduhelm-left-room-lilly-ceo-eyes-competition-with-biogen-alzheimers-drug/ Link to Lilly’s investor site https://investor.lilly.com/news-releases/news-release-details/lillys-donanemab-receives-us-fdas-breakthrough-therapy TAGS: #pharmacist #medicine #health #medical #pharmacology #pharma #healthcare #covid #pharmacystudent #farmacia #doctor #pharmacists #gpat #pharmacylife #pharmacytechnician #pharmacyschool #doctors #pharmd #niper #pharmaceuticals #hospital #nurse #coronavirus #science #pharmacistlife #mbbs #drugs #skincare #industry #pharmacy

Thank you for tuning in to Take Once a Week, if you like this episode, be sure to subscribe! LINKS to stories: https://www.biopharmadive.com/news/scorpion-axel-hoos-ceo-gsk-biotech-startup/602966/ https://endpts.com/spurring-a-biotech-craze-of-its-own-the-uk-plots-out-public-private-investment-plan-as-part-of-1b-industry-infusion/ https://www.fiercepharma.com/pharma/pfizer-victory-vyndaqel-copay-lawsuit-could-spur-drug-pricing-gold-rush-former-hhs-member https://www.pharmatimes.com/news/jardiance_becomes_first_sglt2_inhibitor_to_show_benefit_in_hfpef_1372804 Tags: pharmacy #pharmacist #medicine #health #medical #pharmacology #pharma #healthcare #covid #pharmacystudent #farmacia #doctor #pharmacists #gpat #pharmacylife #pharmacytechnician #pharmacyschool #doctors #pharmd #niper #pharmaceuticals #hospital #nurse #coronavirus #science #pharmacistlife #mbbs #drugs #skincare #industry

In this episode of Take Once a Week, we will discuss the approval of Biogen's Aduhelm as well as some of the major discussions that occurred this past week at ASCO. If you like this episode and others like it, be sure to subscribe! LINKS TO ALL STORIES: https://www.biopharmadive.com/news/biogen-aduhelm-confirmatory-study-fda-approval/601422/ https://www.biopharmadive.com/news/a-first-of-its-kind-alzheimers-drug-raises-heavy-questions-around-who-will/601434/ https://www.biopharmadive.com/news/asco-2021-takeaways-adjuvant-immunotherapy-fate-cullinan/601384/ https://www.fiercepharma.com/pharma/1-2b-deal-for-molnupiravir-u-s-bets-merck-to-finally-provide-effective-covid-19-treatment #pharmacy #news #pharma #pharmaupdates #podcast #academic #vaccine #alzheimers #developments

Welcome to season #2 of QW! Thank you for listening, and be sure to subscribe if you enjoy this podcast. LINKS TO STORIES: https://www.oncnursingnews.com/view/fda-approves-adjuvant-nivolumab-for-resected-esophageal-and-gej-cancer https://www.biopharmadive.com/news/johnson-johnson-rybrevant-bispecific-antibody-pipeline/600696/ https://www.biopharmadive.com/news/biogen-aducanumab-alzheimers-fda-drug-review/600897/ https://www.fiercepharma.com/pharma/glaxosmithkline-scores-a-big-win-its-zofran-litigation-after-fda-repeatedly-rejects

Thank you for listening to episode #9 of Take Once a Week! If you enjoyed this episode and others like it, be sure to subscribe LINKS: https://www.biopharmadive.com/news/pfizer-biontech-coronavirus-vaccine-seek-full-fda-approval/599804/ livescience.com/58790-crispr-explained.html#:~:text=CRISPR%20technology%20is%20a%20simple,of%20diseases%20and%20improving%20crops. https://www.biopharmadive.com/news/crispr-nkarta-gene-editing-nk-cell-therapy/599713/ https://www.fiercepharma.com/pharma/eli-lilly-taps-three-indian-drugmakers-to-bolster-supply-covid-19-drug-baricitinib https://www.biopharmadive.com/news/cdc-acip-pfizer-coronavirus-vaccine-adolescents/600049/

Thank you for tuning in to the newest installment of QW, we hope to see you back here next week. As always, be sure to subscribe, and thank you for listening! LINKS https://www.biopharmadive.com/news/pfizer-coronavirus-vaccine-26-billion-sales/599507/ https://www.biopharmadive.com/news/pfizer-pause-enrollment-bcma-antibody-multiple-myeloma/599512/ https://www.pharmacytimes.com/view/study-finds-breastfeeding-linked-to-higher-neurocognitive-testing-scores https://www.nbcnews.com/health/health-news/cvs-walgreens-have-wasted-more-covid-vaccine-doses-most-states-n1266032

In this episode, we discuss more coronavirus related news, as well as a cancer biotech going public soon. Be sure to subscribe! LINKS: https://www.fiercepharma.com/pharma/covid-19-tracker-johnson-johnson-aims-to-test-shot-kids-president-trump-talks-firing-fauci https://www.cnn.com/2021/04/28/business/eu-pfizer-biontech-deal-astrazeneca-lawsuit-intl/index.html https://people.com/travel/spain-welcome-international-travelers-covid-vaccine-negative-test-june-2021/

https://www.biopharmadive.com/news/johnson-johnson-vaccine-pause-supply-acip-hesitancy/598335/ https://www.biopharmadive.com/news/fda-cder-cavazzoni-woodcock-successor/598235/

Thank you for tuning in to episode #5 of Take Once a Week! Be sure to subscribe if you enjoy this episode and others like it. Links to mentioned stories: https://www.biopharmadive.com/news/johnson-johnson-take-over-emergent-vaccine-factory-astrazeneca/597793/ https://www.fiercepharma.com/marketing/abbvie-s-rinvoq-expansion-hits-a-second-blow-as-fda-delays-2b-atopic-dermatitis-ruling https://www.centerforbiosimilars.com/view/abbvie-accuses-alvotech-of-trade-secret-piracy https://thebutlercollegian.com/2021/04/pharmacy-students-run-covid-19-vaccine-clinic/ https://www.politico.com/news/2021/04/03/pharmacy-covid-vaccine-customer-data-478977 https://www.biopharmadive.com/news/astrazeneca-vaccine-ema-review-rare-blood-clots/597963/

Thank you for checking in to Take Once a Week, in episode 4 we discuss more COVID-related news, including state reopening, vaccine age limit lowering, and new studies. If you like this podcast, be sure to subscribe!